JAMAONCO_OF:09162021
JAMAONCO_OF:09092021
Changes in Life Expectancy After Allogeneic Blood or Marrow Transplantation
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 9, 2021 Media advisory: The full study and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3676?guestAccessKey=3f852df3-f991-471c-82a1-43005d1ca1a3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090921 What the Study Did: Researchers examined changes…
JAMAONCO_OF:09022021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4083?guestAccessKey=401c5452-3b52-469f-9933-a9d18759821c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2907?guestAccessKey=3cf1521e-cf5a-47b4-bc5c-dcb87818f64e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221
Visual Abstract: Ensartinib vs Crizotinib for Anaplastic Lymphoma Kinase−Positive Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, SEPTEMBER 2, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3523?guestAccessKey=7cd645db-d6d0-45a4-9410-6c64a6b47b0c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=090221 Visual Abstract…
JAMAONCO_OF:08292021
JAMAONCO_OF:08262021
Visual Abstract: Effect of Cisplatin, Gemcitabine With or Without Berzosertib in Patients With Advanced Urothelial Carcinoma
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 26, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3441?guestAccessKey=52eb480f-85bb-4d72-a750-c6e4ea579e7a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082621 Visual Abstract Authors:…
Visual Abstract: Effectiveness of Adding Everolimus to First-line Treatment of Advanced Breast Cancer in Premenopausal Women
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 26, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3428?guestAccessKey=6fff4c46-c0eb-49ef-b0f8-67ce316f4a8d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=082621 Visual Abstract Authors:…
JAMAONCO_08192021
Targeted COVID-19 Vaccine Outreach to Marginalized Populations
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 19, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3833?guestAccessKey=e97a3e2d-c47b-4e45-8c0f-d7e191421467&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921 What The Study Did: Researchers at the North Carolina Cancer…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3585?guestAccessKey=cf61110c-09cd-4a01-9041-e0e1412ada0a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921
Visual Abstract: Effects of Exercise on Prostate Cancer Under Active Surveillance
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 19, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3067?guestAccessKey=b71e6940-300a-4fae-b55d-470ef7e132ca&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081921 Visual Abstract…
JAMAONCO_OF:08122021
Visual Abstract: Hypofractionated Image-Guided vs Conventional Radiotherapy for Patients With Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 12, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3186?guestAccessKey=a1568e25-3f53-4723-affc-0c54defb0aa8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081221 Visual Abstract…
JAMAONCO_OF:08112021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.4381?guestAccessKey=e21e391b-70b8-42e8-a852-5a369db2c2f4&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081121
Durability of Response to SARS-CoV-2 BioNTech-Pfizer Vaccination in Patients on Active Anticancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, AUGUST 11, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/2783031?guestAccessKey=2e3b178f-9053-43ef-9178-298837b421a7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=081121 What The Study Did: Researchers describe the antispike IgG antibody…
JAMAONCO_OF:08052021
Visual Abstract: Chemoradiotherapy With S-1 for Older Patients With Esophageal Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, AUGUST 5, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2705?guestAccessKey=1faeb082-838d-4047-865d-058634208242&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=080521 Visual Abstract…
Visual Abstract: Metformin With Chemoradiotherapy Outcomes in Locally Advanced Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 29, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2328?guestAccessKey=1e018809-7b94-4606-9e5b-c6d9b7407f33&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072921 Visual Abstract…
JAMAONCO_OF:07292021
Visual Abstract: Comparing Chemoradiation Plus Metformin vs Chemoradiation for Stage III Non–Small Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 29, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2318?guestAccessKey=d6c68b4c-6e50-4804-b5e2-69f923758f70&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072921 Visual Abstract…
JAMAONCO_OF:07222021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.3127?guestAccessKey=0e0076cb-82fb-4273-ab82-bcf0ecb5431f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221
Prostate Cancer Treatment Among Black, White Patients During Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 22, 2021 Media advisory: The full study and commentary are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2755?guestAccessKey=bd1d5058-6861-4ca9-9126-aec996c6ba22&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221 What The Study Did: This study included…
Visual Abstract: Treatment of High-risk Medulloblastoma in Children
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 22, 2021 Media advisory: The full study and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2224?guestAccessKey=12dbd65b-1312-4066-ab73-41b4830c1581&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221 Visual Abstract…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2582?guestAccessKey=8a0dd195-672e-4a08-b3b4-3144408c2b25&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=072221
JAMAONCO_OF:07152021
Effect of Celecoxib on Survival Among Patients With Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 15, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2193?guestAccessKey=3ea1cbd0-f72c-46a2-b041-313a26c9cde9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071521 Visual Abstract…
Nivolumab Plus Ipilimumab for Advanced Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 15, 2021 Media advisory: The full study is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2209?guestAccessKey=19094b6b-dc8e-4aa5-aa5e-9f8f7587be76&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=071521 Visual Abstract Authors:…
JAMAONCO_OF:07082021
Pfizer-BioNTech Vaccine in Patients Undergoing Cancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JULY 8, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2675?guestAccessKey=a006b52c-6abf-414d-b0b9-b57946450d20&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=070821 What The Study Did: The SARS-CoV-2 BNT162b2 (Pfizer-BioNTech) vaccine…
JAMAONCO_OF:07012021
JAMAONCO_OF:06242021
Survival Outcomes of Breast Cancer Patients Receiving 5 Years vs 2 Years of Bisphosphonate
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 24, 2021 Media advisory: The full study and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1854?guestAccessKey=959725dd-dae7-4cfb-99ed-4fe21347f8a0&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=062421 Visual Abstract …
JAMAONCO_OF:06172021
Association of Convalescent Plasma Therapy With Survival in Patients With Blood Cancers, COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 17, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1799?guestAccessKey=4030509c-d734-45ca-919e-6d5974537caa&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061721 What The Study Did: Researchers evaluated the association of…
JAMAONCO_OF:06102021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1794?guestAccessKey=ef411da1-823b-4a94-b6b8-852b9b886f36&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061021
COVID-19 Vaccine Hesitancy Among Patients With Breast Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JUNE 10, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1962?guestAccessKey=8716f8b1-300f-49b4-be0c-ee2d9ff191a6&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=061021 What The Study Did: This survey study among women…
JAMAONCO_OF:06042021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1499?guestAccessKey=d6c7b910-c310-4af9-8ce5-9992e344d13f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=060421
JAMAONCO_OF:06032021
JAMAONCO_OF:05282021
Seropositivity Following mRNA Vaccination for SARS-CoV-2 in Patients Undergoing Cancer Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MAY 28, 2021 Media advisory: The full article and editorial are linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2155?guestAccessKey=41cd3cc4-ce5f-4607-9680-86c094b38c0a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=053121 What The Study Did: Rates of antispike…
SARS-CoV-2 Antibody Status in Patients With Cancer, Health Care Workers
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), FRIDAY, MAY 28, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.2159?guestAccessKey=8aeadda1-2dff-4136-9127-a1ac36668722&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=053121 What The Study Did: This study evaluates whether there…
JAMAONCO_OF:05272021
JAMAONCO_OF:05202021
JAMAONCO_OF:05132021
COVID-19 Vaccines in Patients With Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MAY 13, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1218?guestAccessKey=deb70871-d54c-413f-a354-affb2bd968e5&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051321 What The Viewpoint Says: Questions regarding the safety of…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.1254?guestAccessKey=843ee507-b75d-4009-bc2a-0db067d319a8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=051321
JAMAONCO_OF:05062021
JAMAONCO_OF:04292021
Association of Cancer Screening Decline With COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 29, 2021 Media advisory: The full study is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0884?guestAccessKey=2e43ed34-0a44-4101-9dae-319f9a2c065c&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042921 What The Study Did: Using insurance claims data, the…
Efficacy, Safety of Carboplatin vs Carboplatin Plus Paclitaxel for Older Women With Ovarian Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 22, 2021 Media advisory: The full article and editorial are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0696?guestAccessKey=0af5b5c5-17f6-422e-b630-b28a279dd1e7&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=042221 Visual Abstract…
JAMAONCO_OF:04222021
JAMAONCO_OF:04152021
JAMAONCO_OF:04082021
JAMAONCO_OF:04012021
Tislelizumab Plus Chemotherapy vs Chemotherapy Alone as Treatment for Advanced Squamous Non–Small-Cell Lung Cancer
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, APRIL 1, 2021 Media advisory: The full article and commentary are linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0366?guestAccessKey=555e2943-4aa6-4726-bf66-459cbc8fbf9d&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=040121 Visual Abstract…
JAMAONCO_OF:03252021
JAMAONCO_OF:03182021
Counseling Patients in COVID-19 Era
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 18, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0125?guestAccessKey=8bb2301f-87a5-4ef2-a8b9-b4854a0509ca&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031821 What The Article Says: An oncologist reflects on how…
Effectiveness of Acupuncture for Chronic Pain Among Cancer Survivors
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, MARCH 18, 2021 Media advisory: The full article is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2021.0310?guestAccessKey=a539fc06-0f39-4fd9-9bde-a74643c025d1&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=031821 Visual Abstract Authors:…
JAMAONCO_OF:03112021
JAMAONCO_OF:03092021
JAMAONCO_OF:03042021
JAMAONCO_OF:02252021
JAMAONCO_OF:02182021
JAMAONCO_OF:02112021
Pragmatic Solutions to Counteract Regressive Effects of COVID-19 Pandemic for Women in Academic Oncology
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 11, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.7681?guestAccessKey=e4ef1db8-32de-456b-940b-f0b627d0e5ec&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=021121 What The Viewpoint Says: How pandemic-related disruptions may adversely…
Effectiveness of Endocrine Therapy for Breast Cancer in Men
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, FEBRUARY 4, 2021 Media advisory: The full article is linked to this news release. A visual abstract is below. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.7442?guestAccessKey=32dca14c-423c-4b79-af71-12de4d1590b9&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=020421 What The Study Did:…
JAMAONCO_OF:02042021
JAMAONCO_OF:01282021
JAMAONCO_OF:01222021
JAMAONCO_OF:01212021
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.7320?guestAccessKey=48e98ecd-6106-4b27-be5e-c6d999170d8e&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012121
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.7338?guestAccessKey=91112afd-2ca8-445f-b30f-0fa6a359060f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=012121
JAMAONCO_OF:01142021
Cancer Screening Tests, Cancer Diagnoses During COVID-19 Pandemic
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 14, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.7600?guestAccessKey=8e9733f4-229b-4616-a1fe-169ee2e23abd&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=011421 What The Study Did: The number of patients undergoing…
JAMAONCO_OF:01072021
Virtual Care At Cancer Center During COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, JANUARY 7, 2021 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6982?guestAccessKey=3851b32e-6501-489b-ac60-39e8281b62a8&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721 What The Study Did: The outcomes of a cancer…
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6758?guestAccessKey=7d0970dc-4d97-458c-8b06-c765db479414&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721
Here’s a link to provide your readers free access to the full-text article
Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6789?guestAccessKey=87987059-df65-4f70-abff-8360f6ebb2ef&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=010721
JAMAONCO_OF:12302020
FDA Oncology Center of Excellence During COVID-19
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), WEDNESDAY, DECEMBER 23, 2020 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6783?guestAccessKey=f0b0978e-0660-492a-baaa-08369b85bc7f&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=122320 What TheViewpoint Says: This Viewpoint discusses initiatives of the…
JAMAONCO_OF:12232020
JAMAONCO_OF:12222020
JAMAONCO_OF:12172020
COVID-19 Social Distancing Efforts: Implications for Cancer Control
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6786?guestAccessKey=28eb8ef2-af95-4069-a4fd-3e5a2dff1e1a&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720 What The Viewpoint Says: The consequences of COVID-19–related social distancing…
SARS-CoV-2 Infection Among Patients With Cancer Undergoing Antitumor Treatment
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 17, 2020 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6778?guestAccessKey=08279ad5-1b7e-48a8-9245-69a69a9cc583&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121720 What The Study Did: The rate of SARS-CoV-2 infection among…
JAMAONCO_OF:12102020
Scientific Rigor in COVID-19 Age
JAMA Oncology EEMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 10, 2020 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6639?guestAccessKey=a99b0027-c0c4-46f9-a736-97205cc977b3&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121020 What The Article Says: This Viewpoint discusses the need…
Analyses of Risk, Racial Disparity, Outcomes Among US Patients With Cancer, COVID-19 Infection
JAMA Oncology EMBARGOED FOR RELEASE: 11 A.M. (ET), THURSDAY, DECEMBER 10, 2020 Media advisory: The full article is linked to this news release. Embed this link to provide your readers free access to the full-text article This link will be live at the embargo time https://jamanetwork.com/journals/jamaoncology/fullarticle/10.1001/jamaoncol.2020.6178?guestAccessKey=d71b15c9-b581-42d2-8430-36d812393207&utm_source=For_The_Media&utm_medium=referral&utm_campaign=ftm_links&utm_content=tfl&utm_term=121020 What The Study Did: This study investigated how patients with…